Clinical Trials
46 trialsNGS as the First-line Treatment in Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan
Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma
Yonsei University
LOTS
National Cheng-Kung University Hospital
SOHUG
Kangbuk Samsung Hospital
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
University of California, San Francisco
ARTIST-II
Samsung Medical Center
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
Yonsei University
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
National Taiwan University Hospital
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Hallym University Medical Center
Docetaxel and S-1 for Advanced Esophageal Cancer
Hallym University Medical Center
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Hallym University Medical Center
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
3G
National University Hospital, Singapore
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Hokuriku-Kinki Immunochemotherapy Study Group
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
Peking Union Medical College Hospital
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
SOPP
Asan Medical Center
Sorafenib Plus S-1 in Advanced Solid Tumors
National Health Research Institutes, Taiwan
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Japan Breast Cancer Research Network
A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Peking University
A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
Yonsei University
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
Hallym University Medical Center
TORCH
Seoul National University Hospital
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer
Yonsei University
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
Chonnam National University Hospital
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Hallym University Medical Center
Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
Hallym University Medical Center
TPSHNSCC
Chonnam National University Hospital
Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Xijing Hospital
TMOG-GC01
Tokyo Metropolitan Oncology Group
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)
Second Military Medical University
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
Samsung Medical Center
S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer
Kyungpook National University Hospital
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
Japan Clinical Cancer Research Organization
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Gyeongsang National University Hospital
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Hokkaido Gastrointestinal Cancer Study Group
Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer
Soonchunhyang University Hospital
A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
A Phase â…¡ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Korea University Anam Hospital